Results for tag: "Wilate"

Wilate is a hematological drug used to treat von Willebrand disease (VWD), a rare bleeding disorder. It is a recombinant form of von Willebrand factor (VWF), a protein that helps the body form blood clots. Wilate is administered intravenously and works by replacing the missing VWF in the body. It is used to reduce the frequency and severity of bleeding episodes in patients with VWD. Wilate is also used to prevent bleeding during surgery or other invasive procedures. The Wilate market is composed of a number of companies that produce and distribute the drug. These companies include CSL Behring, Octapharma, Grifols, and Shire. They are responsible for the research, development, manufacturing, and marketing of Wilate. They also provide support services to healthcare professionals and patients. These companies are committed to providing safe and effective treatments for VWD and other bleeding disorders. Show Less Read more